DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice

Journal of Bone and Mineral Research

Volumn 26, Issue 7, 2011, Pages 1457-1471

  Abdallah, Basem M ^a,b,c   Ditzel, Nicholas ^a   Mahmood, Amer ^a   Isa, Adiba ^c   Traustadottir, Gunnhildur A ^a   Schilling, Arndt F ^d   Ruiz Hidalgo, María José ^e   Laborda, Jorge ^e   Amling, Michael ^f   Kassem, Moustapha ^a,g  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Helwan University   (Egypt)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

BONE REMODELING; DLK1; FA1; OSTEOCLAST; OVX; PREF 1; T CELLS

Indexed keywords

CYTOKINE; DELTA LIKE 1 PROTEIN; ESTROGEN; FETAL ANTIGEN; INTERLEUKIN 7; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BONE MASS; COLONY FORMING UNIT F; CONTROLLED STUDY; CORTICAL BONE; ESTROGEN DEFICIENCY; FEMALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN FUNCTION; TRABECULAR BONE;

ANIMALS; BODY PATTERNING; BODY WEIGHT; BONE AND BONES; BONE RESORPTION; CELL DIFFERENTIATION; COLLAGEN TYPE I; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGIC FACTORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; ORGAN SIZE; OSTEOBLASTS; OVARIECTOMY; PHENOTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 79959514421     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.346     Document Type: Article

References (63)

1. Chambers TJ,. Regulation of the differentiation and function of osteoclasts. J Pathol. 2000; 192: 4-13.
2. Karsenty G, Wagner EF,. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002; 2: 389-406. (Pubitemid 34436569)
3. Harada S, Rodan GA,. Control of osteoblast function and regulation of bone mass. Nature. 2003; 423: 349-355. (Pubitemid 40852710)
4. Blair HC, Robinson LJ, Zaidi M,. Osteoclast signalling pathways. Biochem Biophys Res Commun. 2005; 328: 728-738. (Pubitemid 40208310)
5. Boyle WJ, Simonet WS, Lacey DL,. Osteoclast differentiation and activation. Nature. 2003; 423: 337-342. (Pubitemid 40852708)
6. Takayanagi H,. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007; 7: 292-304. (Pubitemid 46480961)
7. Weitzmann MN, Pacifici R,. Role of the immune system in postmenopausal bone loss. Curr Osteoporos Rep. 2005; 3: 92-97.
8. Weitzmann MN, Pacifici R,. Estrogen regulation of immune cell bone interactions. Ann N Y Acad Sci. 2006; 1068: 256-274. (Pubitemid 43824158)
9. Laborda J,. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol. 2000; 15: 119-129. (Pubitemid 30044297)
10. Jensen CH, Krogh TN, Hojrup P, et al. Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur J Biochem. 1994; 225: 83-92. (Pubitemid 24306230)
11. Abdallah BM, Ding M, Jensen CH, et al. Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology. 2007; 148: 3111-3121. (Pubitemid 46996977)
12. Smas CM, Sul HS,. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell. 1993; 73: 725-734. (Pubitemid 23159011)
13. Moore KA, Pytowski B, Witte L, Hicklin D, Lemischka I,. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci U S A. 1997; 94: 4011-4016. (Pubitemid 27180490)
14. Sakajiri S, O'Kelly J, Yin D, et al. Dlk1 in normal and abnormal hematopoiesis. Leukemia. 2005; 19: 1404-1410. (Pubitemid 41136335)
15. Samulewicz SJ, Seitz A, Clark L, Heber-Katz E,. Expression of preadipocyte factor-1(Pref-1), a delta-like protein, in healing mouse ears. Wound Repair Regen. 2002; 10: 215-221. (Pubitemid 35006782)
16. Crameri RM, Langberg H, Magnusson P, et al. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol. 2004; 558: 333-340. (Pubitemid 39077412)
17. Jensen CH, Jauho EI, Santoni-Rugiu E, et al. Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol. 2004; 164: 1347-1359. (Pubitemid 38387800)
18. Moon YS, Smas CM, Lee K, et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol. 2002; 22: 5585-5592. (Pubitemid 34755767)
19. Berends MJ, Hordijk R, Scheffer H, Oosterwijk JC, Halley DJ, Sorgedrager N,. Two cases of maternal uniparental disomy 14 with a phenotype overlapping with the Prader-Willi phenotype. Am J Med Genet. 1999; 84: 76-79. (Pubitemid 29169240)
20. Abdallah BM, Jensen CH, Gutierrez G, Leslie RG, Jensen TG, Kassem M,. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J Bone Miner Res. 2004; 19: 841-852. (Pubitemid 41094396)
21. Abdallah BM, Boissy P, Tan Q, et al. dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J Biol Chem. 2007; 282: 7339-7351. (Pubitemid 47093687)
22. Raghunandan R, Ruiz-Hidalgo M, Jia Y, et al. Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev. 2008; 17: 495-507. (Pubitemid 351948189)
23. Ding M, Danielsen CC, Hvid I,. Age-related three-dimensional microarchitectural adaptations of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int. 2006; 78: 113-122. (Pubitemid 43228091)
24. Huebner AK, Schinke T, Priemel M, et al. Calcitonin deficiency in mice progressively results in high bone turnover. J Bone Miner Res. 2006; 21: 1924-1934. (Pubitemid 44851569)
25. Abdallah BM, Haack-Sorensen M, Burns JS, et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun. 2005; 326: 527-538. (Pubitemid 39642757)
26. Watanabe T, Komuro Y, Kiyomatsu T, et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res. 2006; 66: 3370-3374.
27. Post S, Abdallah BM, Bentzon JF, Kassem M,. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone. 2008; 43: 32-39.
28. Garcia T, Roman-Roman S, Jackson A, et al. Behavior of osteoblast, adipocyte, and myoblast markers in genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone. 2002; 31: 205-211. (Pubitemid 34754449)
29. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M,. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone. 2006; 39: 181-188. (Pubitemid 43831783)
30. Abdallah BM, Ditzel N, Kassem M,. Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis. Methods Mol Biol. 2008; 455: 89-100.
31. Koga T, Inui M, Inoue K, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004; 428: 758-763. (Pubitemid 38508286)
32. Pessina A, Albella B, Bueren J, et al. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol In Vitro. 2001; 15: 729-740. (Pubitemid 33043962)
33. Bachmann E, Krogh TN, Hojrup P, Skjodt K, Teisner B,. Mouse fetal antigen 1 (mFA1), the circulating gene product of mdlk, pref-1 and SCP-1: isolation, characterization and biology. J Reprod Fertil. 1996; 107: 279-285.
34. Jensen CH, Krogh TN, Stoving RK, Holmskov U, Teisner B,. Fetal antigen 1 (FA1), a circulating member of the epidermal growth factor (EGF) superfamily: ELISA development, physiology and metabolism in relation to renal function. Clin Chim Acta. 1997; 268: 1-20. (Pubitemid 28066798)
35. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaisse JM,. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res. 2005; 65: 9943-9952. (Pubitemid 41541475)
36. Kalajzic I, Kalajzic Z, Kaliterna M, et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res. 2002; 17: 15-25. (Pubitemid 33150992)
37. Floridon C, Jensen CH, Thorsen P, et al. Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation. 2000; 66: 49-59. (Pubitemid 30639225)
38. Takayanagi H, Kim S, Koga T, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3: 889-901. (Pubitemid 35460788)
39. Nanes MS,. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003; 321: 1-15. (Pubitemid 37421390)
40. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R,. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood. 2000; 96: 1873-1878. (Pubitemid 30661073)
41. Weitzmann MN, Pacifici R,. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann N Y Acad Sci. 2007; 1116: 360-375. (Pubitemid 350274346)
42. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995; 154: 180-191.
43. da Rocha ST, Charalambous M, Lin SP, et al. Gene dosage effects of the imprinted delta-like homologue 1 (dlk1/pref1) in development: implications for the evolution of imprinting. PLoS Genet. 2009; 5: e1000392.
44. Wang Y, Sul HS,. Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab. 2009; 9: 287-302.
45. Harkness L, Taipaleenmaki H, Mahmood A, et al. Isolation and differentiation of chondrocytic cells derived from human embryonic stem cells using dlk1/FA1 as a novel surface marker. Stem Cell Rev Rep. 2009; 5: 353-368.
46. Garces C, Ruiz-Hidalgo MJ, Bonvini E, Goldstein J, Laborda J,. Adipocyte differentiation is modulated by secreted delta-like (dlk) variants and requires the expression of membrane-associated dlk. Differentiation. 1999; 64: 103-114. (Pubitemid 29077837)
47. Smas CM, Sul HS,. Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-. Crit Rev Eukaryot Gene Expr. 1997; 7: 281-298. (Pubitemid 28520351)
48. Pacifici R,. T cells and post menopausal osteoporosis in murine models. Arthritis Res Ther. 2007; 9: 102.
49. van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP,. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2003; 62: 113-119. (Pubitemid 36135385)
50. Tsubaki M, Kato C, Manno M, et al. Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways. Mol Cell Biochem. 2007; 304: 53-60. (Pubitemid 47456852)
51. Horton JE, Harper J, Harper E,. Platelet factor 4 regulates osteoclastic bone resorption in vitro. Biochim Biophys Acta. 1980; 630: 459-462. (Pubitemid 10027811)
52. Yang M, Mailhot G, Mackay CA, Mason-Savas A, Aubin J, Odgren PR,. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro. Blood. 2006; 107: 2262-2270. (Pubitemid 43345543)
53. Mastellos D, Lambris JD,. Complement: more than a 'guard' against invading pathogens? Trends Immunol. 2002; 23: 485-491. (Pubitemid 35248043)
54. Sato T, Abe E, Jin CH, et al. The biological roles of the third component of complement in osteoclast formation. Endocrinology. 1993; 133: 397-404. (Pubitemid 23206420)
55. Turk B, Turk V, Turk D,. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem. 1997; 378: 141-150. (Pubitemid 27230596)
56. Yasuda Y, Kaleta J, Bromme D,. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev. 2005; 57: 973-993. (Pubitemid 40703885)
57. Hayashi H, Nakahama K, Sato T, et al. The role of Mac-1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor-kappaB ligand. FEBS Lett. 2008; 582: 3243-3248.
58. Burns E, Bachrach G, Shapira L, Nussbaum G,. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol. 2006; 177: 8296-8300. (Pubitemid 44893789)
59. Chacon MR, Miranda M, Jensen CH, et al. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro. Int J Obes (Lond). 2008; 32: 1122-1129. (Pubitemid 351986196)
60. Huang CC, Chuang JH, Huang LL, et al. The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia. J Pathol. 2004; 202: 172-179. (Pubitemid 38208654)
61. Pasparakis M,. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009; 9: 778-788.
62. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A. 2001; 98: 13960-13965. (Pubitemid 33116006)
63. Takayanagi H,. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5: 667-676.